University Hospital of Toulouse
Toulouse, 31000, France
NCT Number: NCT02829580
Sickle cell disease (SCD) is an inherited disorder characterized by recurrent painful crises with ischemia resulting from vascular occlusion. Adults with SCD have increased arterial stiffness and reduced flow-mediated dilation (FMD), due to impaired release of substances such as nitric oxide.
The present study assess the vascular properties of carotid and brachial arteries in children with SCD compared with a control group without cardiovascular risk factors.
Looking for future studies?
Notify Me7 year–18 year
All sexes
Interventional
Not applicable
Toulouse, 31000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Sickle cell group :
Control group : Children recruited in a previous study :
Exclusion criteria
Sickle cell group :
Control group :
Children with intercurrent diseases: obesity, IUGR, hypertension, renal failure, infectious diseases (including HIV, Hepatitis C) or chronic inflammatory
Measures by Doppler and study of endothelial function
Time frame: baseline
Evaluation parameter of endothelial function (brachial artery): flow dependent dilatation (expressed in%)
Time frame: baseline
The thickness of the intima media (ITM) on the right common carotid
Time frame: baseline
systolic and diastolic diameters (sD, dD)
Time frame: baseline
match the measurement on the compliance and distensibility cross sectional (CCS, DCS)
Time frame: baseline
diastolic wall stress (DWS)
University Hospital, Toulouse
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04691323
Anemia, Anemia, Hemolytic
Chicago, Illinois, United States
View Trial DetailsNCT04688411
Anemia, Anemia, Hemolytic
Chicago, Illinois, United States
View Trial DetailsNCT05405114
Anemia, Anemia, Hemolytic
Mobile, Alabama, United States
View Trial DetailsNCT07721155
Anemia, Anemia, Hemolytic
Amsterdam, Netherlands
View Trial Details